Contact
Please use this form to send email to PR contact of this press release:
Five Prime Therapeutics Announces $25 Million Payment by Bristol-Myers Squibb for Cabiralizumab Development Milestone
TO:
Please use this form to send email to PR contact of this press release:
Five Prime Therapeutics Announces $25 Million Payment by Bristol-Myers Squibb for Cabiralizumab Development Milestone
TO: